JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Common Shares Outstanding
JW (Cayman) Therapeutics Co Ltd
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Common Shares Outstanding
¥407.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Common Shares Outstanding
¥1.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Common Shares Outstanding
¥1.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Common Shares Outstanding
¥1.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Common Shares Outstanding
¥2.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Common Shares Outstanding
¥216.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
407.6m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Common Shares Outstanding amounts to 407.6m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
2%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for JW (Cayman) Therapeutics Co Ltd have been 2% over the past three years , 2% over the past five years .